CAS: 16320-04-0; Gestrinone

该化合物是一种合成类固醇,具有先天性和先天性,主要用于治疗内分泌症和其他妇科疾病,被归类为睾酮合成衍生物,通过调制荷尔蒙途径展示独特的行动机制.Gestrinone功能通过抑制蛋白激素分泌,进而降低雌激素水平,从而减轻与雌激素依赖性条件有关的症状.该化合物通常以口服方式施用,其特点是其亲脂性,允许体内有效吸收和分布.其化学结构包括环球环,有助于其生物活动.虽然Gestrinone在管理某些医疗条件方面是有效的,但也可能产生副作用,包括荷尔蒙不平衡和对肝功能的潜在影响.与任何药物一样,它的使用应该受到保健专业人员的密切监测,以确保安全和功效.

结构式图片

欧盟法规

ECHA物质C&L通报

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-12054512-B2
    优先权日:2017-11-10
    标 题 :Sting modulator compounds, and methods of making and using
    发明人:VYSKOCIL STEPAN; CIAVARRI JEFFREY; CULLIS COURTNEY; ENGLAND DYLAN BRADLEY; GOULD ALEXANDRA E; GREENSPAN PAUL; HU YONGBO; LANGSTON STEVEN; LI GANG; MIZUTANI HIROTAKE; OKANIWA MASANORI
    权利人:TAKEDA PHARMACEUTICALS CO
    摘要:The present disclosure provides STING modulators/agonists, and methods of synthesis and methods for using for the prophylaxis or treatment of cancer and other STING-related diseases.The present disclosure relates to a compound represented by the Formula (I):wherein each symbol is as defined in the description, or a pharmaceutically acceptable salt thereof.

    专利号:US-7504543-B2
    优先权日:2004-03-18
    标 题:Polyether alcohols and method for the production of polyether alcohols for polyurethane synthesis
    发明人:RUPPEL RAIMUND; BAUM EVA; OSTROWSKI THOMAS; HARRE KATHRIN; BLEUEL ELKE
    权利人:BASF AG
    摘要:The invention relates to polyether alcohols, to a process for preparing polyether alcohols by reacting alkylene oxides in the presence of a double metal cyanide (DMC) catalyst with at least one saturated OH component which may, if appropriate, have previously been reacted with an alkylene oxide, wherein an antioxidant is added before or during the reaction, and also to the further processing of the polyether alcohols to form polyurethanes.

    专利号:US-8093415-B2
    优先权日:2001-11-16
    标题:Polyunsaturated fatty acid monovalent and divalent metal salt synthesis
    发明人:LUCHINI DANIEL NESTOR; STROHMAIER GEORGE K; FREDERIKSEN EILER D; HAWKES JAMES G; DULL BOB J
    权利人:LUCHINI DANIEL NESTOR; STROHMAIER GEORGE K; FREDERIKSEN EILER D; HAWKES JAMES G; DULL BOB J; VIRTUS NUTRITION LLC
    摘要:Methods for the preparation of a free-flowing, storage-stable fatty acid metal salt product by forming a reactive admixture of (a) an unsaturated fatty acid glyceride feedstock; and (b) from about 1 mol to about 3 mol of at least one monovalent metal hydroxide or at least one divalent metal hydroxide; and heating the admixture to a temperature at which said fatty acid glycerides saponify to form fatty acid metals salts; wherein said monovalent metal is potassium; and wherein said divalent metal is selected from the group consisting of calcium, copper, magnesium and zinc. The fatty acid glycerides are saponified in an atmosphere in which the partial pressure of oxygen has been reduced by an amount effective to provide an improvement in storage stability until a free-flowing, storage-stage product is obtained. Storage stable metal salts of unsaturated fatty acids prepared by the inventive methods are also disclosed.

    专利号:EP-1765964-A4
    优先权日:2004-04-30
    标 题:SYNTHESIS OF METALLIC SALTS OF MONOVALENT AND DIVALENT POLYUNSATURATED FATTY ACIDS

    专利号:US-2008280877-A1
    优先权日:2007-05-10
    标 题:Azetidines
    发明人:DACK KEVIN NEIL; SKERRATT SARAH ELIZABETH; YEAP SIEW KUEN
    权利人:PFIZER
    摘要:The invention relates to EP2 antagonist azetidines of formula (I) n n n n n n n n n n wherein Ar, R 1 , X, and Z are as defined herein, to their use in medicine, particularly in the treatment of endometriosis and/or uterine fibroids, to intermediates useful in their synthesis, and to compositions containing them.

    专利号:US-2010256109-A1
    优先权日:2007-11-15
    标 题 :Azetidines As EP2 Antagonists
    发明人:SKERRATT SARAH ELIZABETH; DACK KEVIN NEIL
    权利人:SKERRATT SARAH ELIZABETH; DACK KEVIN NEIL
    摘要:The present invention relates to a class of EP2 antagonistazetidines of general formula (I), wherein the variables and substituents are as defined herein, and especially to EP2 antagonist compounds, to their use in medicine, particularly in the treatment of endometriosis and/or uterine fibroids (leiomyomata) and to intermediates usefulin their synthesis and to compositions containing them.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Wu X, Xu Y. Gestrinone combined with ultrasound-guided aspiration and ethanol injection for treatment of chocolate cyst of ovary. J Obstet Gynaecol Res. 2015 May;41(5):712-6. doi: 10.1111/jog.12612. Epub 2014 Nov 25. doi: 10.1016/j.biopha.2012.02.003. Epub 2012 Mar 27. doi: 10.3760/cma.j.issn.0529-567X.2016.02.004. Chinese. doi: 10.1097/AOG.0b013e3181d43ae4. doi: 10.1016/j.talanta.2010.07.067. Epub 2010 Aug 3.
    7: Coutinho EM. Gestrinone in the treatment of myomas. Acta Obstet Gynecol Scand Suppl. 1989;150:39-46. Japanese.
    13: Forbes KL, Thomas FJ. Tissue and endocrine responses to gestrinone and danazol in the treatment of endometriosis. Reprod Fertil Dev. 1993;5(1):103-9. Chinese. doi: 10.3390/bios2030291.

    合成参考文献


    参考文献:10.1007/s00216-010-3484-3
    摘要:Peters RJB, Oosterink JE, Stolker AAM, Georgakopoulos C, Nielen MWF. Generic sample preparation combined with high-resolution liquid chromatography–time-of-flight mass spectrometry for unification of urine screening in doping-control laboratories. Analytical and Bioanalytical Chemistry. 2010 Feb 16;396(7):2583–98. doi: 10.1007/s00216-010-3484-3.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知